CompletedPhase 2NCT02399592

Tocotrienol as a Nutritional Supplement in Patients With Advanced Ovarian Cancer

Studying Malignant epithelial tumor of ovary

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Vejle Hospital
Principal Investigator
Anders Jakobsen, DMSc
Department of Oncology, Vejle Hospital
Intervention
Bevacizumab(drug)
Enrollment
23 enrolled
Eligibility
18 years · FEMALE
Timeline
20152019

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02399592 on ClinicalTrials.gov

Other trials for Malignant epithelial tumor of ovary

Additional recruiting or active studies for the same condition.

See all trials for Malignant epithelial tumor of ovary

← Back to all trials